Literature DB >> 30405814

The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.

Shuang-Yan Lin1, Yan-Bo Lv1, Gen-Xiang Mao2, Xu-Jiao Chen3, Fang Peng1.   

Abstract

Centromere protein U (CENPU) is a novel transcriptional repressor that is associated with different types of cancer. However, its function in breast cancer is poorly understood. In the present study, it was identified that CENPU was highly expressed in breast cancer tissues compared with expression in normal breast tissues (P=0.001). Furthermore, the CENPU mRNA level in tumors was often elevated, compared with the matched adjacent normal breast cancer tissue specimens in the dataset from The Cancer Genome Atlas database (n=106; P<0.001). To understand the function of CENPU in human breast carcinogenesis, its effects on the proliferation, apoptosis and cell cycle progression of MDA-MB-231 cells were examined using the lentiviral-mediated CENPU knockdown approach. The RNA and protein expression levels in the transfected cells were monitored using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The mRNA and protein expression levels of the CENPU gene were significantly lower in the CENPU-shRNA transfected cells than in the control (P<0.01), indicating successful gene expression knockdown. Post-transfection, cell counting and MTT analysis revealed that the proliferation activity was significantly suppressed in CENPU knockdown cells relative to the control (P<0.01). Additionally, fluorescence activated cell sorting analysis revealed that the (G2+S) phase fraction was significantly declined in CENPU knockdown cells relative to the control; while the G1 phase fraction was significantly increased (P<0.01) and the percentage of the apoptotic cells was significantly increased (P<0.01). In conclusion, downregulation of CENPU gene expression may inhibit cell proliferation and cell cycle progression, and increase the apoptosis of the breast cancer cells. These results suggested a possible function of this protein in breast cancer pathogenesis and prognosis.

Entities:  

Keywords:  apoptosis; breast cancer; cell cycle; centromere protein U; proliferation

Year:  2018        PMID: 30405814      PMCID: PMC6202484          DOI: 10.3892/ol.2018.9477

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Clean Western blots of membrane proteins after yeast heterologous expression following a shortened version of the method of Perini et al.

Authors:  J M Fuentes; A M Lompré; J V Møller; P Falson; M le Maire
Journal:  Anal Biochem       Date:  2000-10-15       Impact factor: 3.365

3.  CENP-U cooperates with Hec1 to orchestrate kinetochore-microtubule attachment.

Authors:  Shasha Hua; Zhikai Wang; Kai Jiang; Yuejia Huang; Tarsha Ward; Lingli Zhao; Zhen Dou; Xuebiao Yao
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

4.  The constitutive centromere component CENP-50 is required for recovery from spindle damage.

Authors:  Yukinori Minoshima; Tetsuya Hori; Masahiro Okada; Hiroshi Kimura; Tokuko Haraguchi; Yasushi Hiraoka; Ying-Chun Bao; Toshiyuki Kawashima; Toshio Kitamura; Tatsuo Fukagawa
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  Therapeutic targeting of tumor suppressor genes.

Authors:  Luc G T Morris; Timothy A Chan
Journal:  Cancer       Date:  2014-12-29       Impact factor: 6.860

Review 6.  Molecular targeted therapy: Treating cancer with specificity.

Authors:  Yeuan Ting Lee; Yi Jer Tan; Chern Ein Oon
Journal:  Eur J Pharmacol       Date:  2018-07-20       Impact factor: 4.432

7.  cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP.

Authors:  Silva H Hanissian; Umar Akbar; Bin Teng; Zorica Janjetovic; Anne Hoffmann; Johann K Hitzler; Norman Iscove; Kristin Hamre; Xiaoping Du; Yiai Tong; Suraj Mukatira; Jon H Robertson; Stephan W Morris
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

8.  Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction.

Authors:  Kyung S Lee; Doo-Yi Oh; Young H Kang; Jung-Eun Park
Journal:  Cell Div       Date:  2008-01-23       Impact factor: 5.130

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

Review 10.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.

Authors:  Jaafar Makki
Journal:  Clin Med Insights Pathol       Date:  2015-12-21
View more
  5 in total

1.  High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients.

Authors:  Zhongyuan Cui; Lijia Xiao; Fengsui Chen; Jielong Wang; Haiyan Lin; Dongliang Li; Zhixian Wu
Journal:  Dis Markers       Date:  2021-08-17       Impact factor: 3.434

2.  A nomogram based on CENPP expression for survival prediction in breast cancer.

Authors:  Heyan Chen; Shengyu Pu; Shibo Yu; Xiaoqin Liao; Jianjun He; Huimin Zhang
Journal:  Gland Surg       Date:  2021-06

3.  The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.

Authors:  Shuangyan Lin; Mingyuan Zhao; Yanbo Lv; Genxiang Mao; Shiping Ding; Fang Peng
Journal:  Aging (Albany NY)       Date:  2021-04-26       Impact factor: 5.682

4.  LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes.

Authors:  Olivier Collier; Véronique Stoven; Jean-Philippe Vert
Journal:  PLoS Comput Biol       Date:  2019-09-30       Impact factor: 4.475

5.  Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.

Authors:  Chengrui Li; Yufeng Wan; Weijun Deng; Fan Fei; Linlin Wang; Fuwei Qi; Zhong Zheng
Journal:  Open Med (Wars)       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.